ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2460

Health Care Segregation, but Not Metropolitan Area Segregation, Magnifies Racial Disparities in Hospital Outcomes of Pediatric Lupus

Joyce Chang1, Jessica Liu1, Laura Berbert1, Edie Weller1, Gabrielle Alonzi1, Emily Smitherman2, Pooja Patel3, Mary Beth Son4 and Karen Costenbader5, 1Boston Children's Hospital, Boston, MA, 2University of Alabama at Birmingham, Birmingham, AL, 3Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 4Division of Immunology, Boston Children's Hospital, Boston, MA, 5Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Meeting: ACR Convergence 2023

Keywords: Access to care, Administrative Data, Disparities, Pediatric rheumatology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: Abstracts: Healthcare Disparities in Rheumatology

Session Type: Abstract Session

Session Time: 2:00PM-3:30PM

Background/Purpose: Racial disparities and hospital-level variation in pediatric SLE (pSLE) outcomes are well described, but it is not known how the racial and ethnic composition of the populations hospitals serve contributes to these disparities. Using de-identified data, we evaluated whether hospital minority composition, a measure of health care segregation, or metropolitan statistical area (MSA)-level racial or ethnic segregation modify racial disparities in pSLE outcomes.

Methods: We linked data from the Pediatric Health Information System (2006–2021) for patients 5-26 years old hospitalized for SLE to MSA-level 2020 U.S. Census and American Community Survey data. Primary outcomes assessed at the patient level were intensive care unit (ICU) stays and adverse renal outcomes (end stage renal disease, dialysis, or transplant). Hospital Black racial composition and Hispanic ethnic composition were based on % of all admissions (any indication) reported by each hospital. MSA segregation was measured by census-derived Dissimilarity Index (DI) for Black/Non-Hispanic White (NHW) or Hispanic/Non-Hispanic segregation, reflecting evenness of spatial distribution of two groups across census tracts within an MSA. We compared indices using mixed effects logistic models with hospital-level random effects, adjusted for calendar period, sociodemographics, severity indicators, and hospital volume. We stratified hospitals by above or below the median for Black or Hispanic composition and by high or low Black/NHW segregation.

Results: Of 8125 patients (at 47 hospitals), 2293 (28%) ever required ICU care and 698 (9%) had an adverse renal outcome (Table 1). Higher hospital Hispanic composition, but not Black racial composition, associated with lower overall odds of ICU stay (OR 0.99 [0.986-0.996] per % increase). Significant Black vs. NHW disparity in ICU care was observed only at hospitals with high Black racial composition, whereas Hispanic vs. NHW disparities in ICU stay did not differ by hospital Hispanic composition (Fig 1).

Similarly, the magnitude of Black vs. NHW disparity in renal outcomes was larger at hospitals with high Black racial composition (OR 2.0 [1.4-2.8] vs. 1.7 [1.1-2.4]). Moreover, disparities in renal outcomes for Hispanic White vs. NHW children were only observed at hospitals with high Black racial composition (Fig 2A). We observed the opposite for Hispanic composition, where Hispanic White, Asian, and American Indian/Other vs. NHW disparities were only apparent at hospitals with low Hispanic composition (Fig 2B).

MSA-level DI was not significantly associated with either outcome. Black vs. NHW disparities did not differ by high (DI >0.6) vs. low MSA Black/NHW segregation (Fig 1C, 2C). No MSAs met criteria for high Hispanic/Non-Hispanic segregation.

Conclusion: Racial disparities in pSLE outcomes are magnified at hospitals serving a greater proportion of Black patients, which may reflect negative effects of health care segregation and inequitable hospital resources. Metropolitan level measures of segregation explain little variance in hospital outcomes, therefore linkages to small geographic units must be included in health care databases to understand local factors that contribute to poor outcomes.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: J. Chang: None; J. Liu: None; L. Berbert: None; E. Weller: None; G. Alonzi: None; E. Smitherman: None; P. Patel: AbbVie/Abbott, 12, Site Principal Investagator, Pfizer, 12, Site Principal Investigator; M. Son: None; K. Costenbader: Amgen, 2, 5, AstraZeneca, 5, Bristol-Myers Squibb(BMS), 2, Cabaletta, 2, Eli Lilly, 2, Exagen Diagnostics, 5, Gilead, 5, GlaxoSmithKlein(GSK), 2, 5, Janssen, 2, 5.

To cite this abstract in AMA style:

Chang J, Liu J, Berbert L, Weller E, Alonzi G, Smitherman E, Patel P, Son M, Costenbader K. Health Care Segregation, but Not Metropolitan Area Segregation, Magnifies Racial Disparities in Hospital Outcomes of Pediatric Lupus [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/health-care-segregation-but-not-metropolitan-area-segregation-magnifies-racial-disparities-in-hospital-outcomes-of-pediatric-lupus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/health-care-segregation-but-not-metropolitan-area-segregation-magnifies-racial-disparities-in-hospital-outcomes-of-pediatric-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology